Zepbound (tirzepatide) is a prescription medication developed by Eli Lilly and Company, approved by the FDA for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions like high blood pressure, type 2 diabetes, or high cholesterol. It works as a dual GLP-1 and GIP receptor agonist, mimicking hormones that regulate appetite and blood sugar, leading to significant weight loss—up to 20% of body weight in clinical trials. It’s administered weekly via injection and is also approved for treating moderate-to-severe obstructive sleep apnea in adults with obesity.
Zepbound is essentially the obesity-focused branding of tirzepatide; the same drug is marketed as Mounjaro for type 2 diabetes treatment.
Recent News: Price Cuts as of December 1, 2025
Eli Lilly announced significant price reductions for single-dose vials of Zepbound available through its direct-to-consumer platform, LillyDirect, to improve access amid surging demand for weight-loss drugs. This follows a November 2025 deal with the Trump administration to lower prices for Medicare and Medicaid patients starting in 2026 (e.g., $245/month for Medicare with a $50 copay). The cuts aim to address barriers like high list prices and inconsistent insurance coverage.
New Cash Prices via LillyDirect (Self-Pay Journey Program)
These prices apply to out-of-pocket purchases for patients with a valid prescription. Vials require manual drawing and self-injection.
| Dose | Previous Price (per month) | New Price (per month) | Notes |
|---|---|---|---|
| 2.5 mg (starting dose) | $349 | $299 | – |
| 5 mg | $499 | $399 | – |
| 7.5 mg – 15 mg (all higher doses) | $499 | $449 | Discount of up to 20% |
- List Price (without discounts): ~$1,086 per month for pens or vials.
- Availability: Ships directly to your home via LillyDirect. Sign up at lilly.com/lillydirect for prescriptions and delivery.
- Savings Options: Commercially insured patients may qualify for a savings card (up to $469 off a 1-month supply, expires 12/31/2025; not for government insurance). Check zepbound.lilly.com for eligibility.
How to Get Zepbound
- Consult a Doctor: Get a prescription—LillyDirect offers telehealth consultations.
- Purchase Options:
- LillyDirect: Vials or pens with home delivery (cash or insurance).
- Pharmacies: Available at major chains; use the savings card if eligible.
- Insurance: Coverage varies; appeal denials if needed. Medicare/Medicaid expansions start 2026.
- Side Effects: Common ones include nausea, diarrhea, and injection-site reactions. Serious risks include thyroid tumors or pancreatitis—discuss with your doctor.
Eli Lilly’s stock dipped ~1.65% on December 1 following the announcement, but the company hit $1 trillion market cap last month, driven by Zepbound’s success (now the world’s top-selling drug). For more details or to start, visit zepbound.lilly.com or consult a healthcare provider.
